Hjem › Wilms tumor › Tennessee › Memphis
Kliniske studier for Wilms tumor i Memphis, TN
6 studier for Wilms tumor søker deltakere på steder i og rundt Memphis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
RekruttererFase 2
- Saint Jude Children's Research Hospital, Memphis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekruttererFase 1/2
- Saint Jude Children's Research Hospital, Memphis
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
RekruttererFase 2
- Saint Jude Children's Research Hospital, Memphis
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
RekruttererFase 1
- St. Jude Children's Research Hospital, Memphis
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
RekruttererFase 1/2
- St. Jude Children's Research Hospital, Memphis
Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation
RekruttererFase 2
- St.Jude Children's Research Hospital, Memphis
Wilms tumor-studier i andre byer
- Washington, DC7 studier
- Atlanta, GA5 studier
- Houston, TX4 studier
- Greenburgh, NY4 studier
- Minneapolis, MN4 studier
- Chicago, IL4 studier
- Mountain View, CA4 studier
- Philadelphia, PA4 studier
- St. Louis, MO4 studier
- New York City, NY4 studier
- Los Angeles, CA4 studier
- Cincinnati, OH4 studier
Andre studier i Memphis
- Kreft (alle typer)31 studier
- Ikke-småcellet lungekreft23 studier
- Brystkreft22 studier
- Lungekreft18 studier
- Sigdcelleanemi18 studier
- Akut lymfoblastisk leukemi16 studier
- Akut myelogen leukemi15 studier
- Hjertesvikt13 studier
- Bløtvevssarkom11 studier
- Melanom11 studier
- Prostatakreft11 studier
- Kolorektal kreft11 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.